Empyrean Bioscience Announces Preventx Effective Against Anthrax in Laboratory Tests
``We are very excited to receive in vitro test results from an independent laboratory that demonstrate the effectiveness of Preventx® against anthrax,'' said Richard C. Adamany, Empyrean's president and chief executive officer. ``Of course, we will need to do further studies and obtain FDA approval to market Preventx® for this indication.''
``This successful test is the most recent in a series of bioterrorism susceptibility tests managed by Focus Technologies for the biopharmaceutical industry. We have been able to determine, in vitro, the effectiveness of most commercially available antibiotic products in combating anthrax and other potential bioterrorism agents,'' commented Daniel Sahm, Ph.D., Focus' chief scientific officer.
Preventx® hand sanitizer and first-aid antiseptic lotion features an alcohol-free, aloe-enriched formula that kills 99.9% of most common disease-causing germs for up to four hours, and is available nationally at Walgreens, Rite Aid and Eckerd, and regionally at Fred Meyer, Longs Drug, Duane Reade, Weiss Markets, Marc's, Medic Drug, Heinen's Fine Foods and other fine retailers nationwide.
Other news from the department science
Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.